Published in Surv Ophthalmol on April 28, 2006
Ophthalmic parasitosis: a review article. Interdiscip Perspect Infect Dis (2012) 0.83
Advances in methods and algorithms in a modern quantum chemistry program package. Phys Chem Chem Phys (2006) 6.51
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA (2011) 6.39
Generalized born model with a simple smoothing function. J Comput Chem (2003) 4.36
Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures. J Comput Chem (2004) 3.83
Brow ptosis after temporal artery biopsy: incidence and associations. Ophthalmology (2012) 2.38
Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv (2013) 2.02
Air reflux and other sequelae following endoscopic dacryocystorhinostomy. Ophthal Plast Reconstr Surg (2013) 1.97
Perioperative visual loss in ocular and nonocular surgery. Clin Ophthalmol (2010) 1.92
Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol (2012) 1.69
Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J (2009) 1.66
Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology (2008) 1.63
Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology (2011) 1.62
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J (2008) 1.58
Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol (2005) 1.58
Ocular ethambutol toxicity. Mayo Clin Proc (2003) 1.57
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Am J Ophthalmol (2007) 1.56
Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv (2005) 1.49
"Sutureless" repair of orbital floor and rim fractures. Ophthalmology (2008) 1.49
Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. JACC Cardiovasc Interv (2008) 1.48
Transient homonymous hemianopia and positive visual phenomena in patients with nonketotic hyperglycemia. Arch Ophthalmol (2007) 1.46
False-negative apraclonidine testing in acute Horner syndrome. Can J Ophthalmol (2009) 1.43
Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.40
Preprocedural white blood cell count as a predictor of death and major adverse cardiac events in patients undergoing percutaneous coronary intervention with drug-eluting stents. J Invasive Cardiol (2009) 1.40
Re-examination of the antithrombotic regimen in the STEMI-RADIAL trial. J Am Coll Cardiol (2014) 1.39
Orbital decompression as an alternative management strategy for patients with benign tumors located at the orbital apex. Ophthalmology (2006) 1.39
Percutaneous intervention of left main coronary artery compression by pulmonary artery aneurysm. Catheter Cardiovasc Interv (2010) 1.39
Saphenous vein graft intervention: status report 2014. J Invasive Cardiol (2014) 1.39
Fibromuscular dysplasia of the left anterior descending coronary artery. JACC Cardiovasc Interv (2012) 1.38
Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology (2013) 1.36
Drug-eluting stent fracture: incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv (2010) 1.32
Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One (2012) 1.30
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. PLoS One (2012) 1.28
Wooden intraorbital foreign body injuries: clinical characteristics and outcomes of 23 patients. Ophthal Plast Reconstr Surg (2010) 1.07
Pegylated interferon alpha-associated optic neuropathy. J Neuroophthalmol (2010) 1.06
Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis. Mol Cell Proteomics (2008) 1.05
Orbital burkitt lymphoma in immunocompetent patients: a report of 3 cases and a review of the literature. Ophthal Plast Reconstr Surg (2009) 1.00
Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target (2010) 0.99
Optic neuropathy in vitamin B12 deficiency. Eur J Intern Med (2005) 0.97
The ultrasonic bone aspirator in transnasal endoscopic dacryocystorhinostomy. Ophthal Plast Reconstr Surg (2013) 0.97
Transplant coronary artery disease. JACC Cardiovasc Interv (2010) 0.96
Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin. J Neuroophthalmol (2008) 0.94
Calculation of protein heat capacity from replica-exchange molecular dynamics simulations with different implicit solvent models. J Phys Chem B (2008) 0.94
Odontogenic orbital cellulitis. Ophthal Plast Reconstr Surg (2008) 0.92
Posterior vitreous detachment in AION. Ophthalmology (2009) 0.90
Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol (2009) 0.90
Bone from an orbital floor fracture causing an intraocular foreign body. Am J Ophthalmol (2005) 0.90
Patent foramen ovale: clinical manifestations and treatment. Rev Cardiovasc Med (2008) 0.89
Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase. PLoS One (2011) 0.89
Occlusive vasculitis in a patient with concomitant West Nile virus infection. Am J Ophthalmol (2003) 0.89
FIEFDom: a transparent domain boundary recognition system using a fuzzy mean operator. Nucleic Acids Res (2008) 0.87
Comparison between self-guided Langevin dynamics and molecular dynamics simulations for structure refinement of protein loop conformations. J Comput Chem (2011) 0.87
Sampling of near-native protein conformations during protein structure refinement using a coarse-grained model, normal modes, and molecular dynamics simulations. Proteins (2008) 0.87
Structure refinement of protein model decoys requires accurate side-chain placement. Proteins (2012) 0.87
Macular exudative retinal detachment in a patient with a dural cavernous sinus fistula. Arch Ophthalmol (2006) 0.87
Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors. Adv Virol (2011) 0.86
Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis. Antimicrob Agents Chemother (2013) 0.86
Preliminary study of positron emission tomography in the detection and management of orbital malignancy. Ophthal Plast Reconstr Surg (2006) 0.86
Can hygroscopic expansion compensate polymerization shrinkage? Part I. Deformation of restored teeth. Dent Mater (2010) 0.86
Comatic aberration as a cause of monocular diplopia. J Cataract Refract Surg (2006) 0.85
Ocular and orbital pain for the headache specialist. Curr Neurol Neurosci Rep (2011) 0.85
Evaluation and management of pediatric orbital fractures in a primary care setting. Orbit (2007) 0.84
Another case of leber hereditary optic neuropathy in an octogenarian. J Neuroophthalmol (2009) 0.84
Orbital hemorrhage and compressive optic neuropathy in patients with midfacial fractures receiving low-molecular weight heparin therapy. J Oral Maxillofac Surg (2009) 0.84
Bilateral retinal occlusion progressing to long-lasting blindness in severe preeclampsia. Obstet Gynecol (2002) 0.84
A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol (2014) 0.83
Treatment of vision loss in giant cell arteritis. Curr Treat Options Neurol (2012) 0.83
Prevalence of optic nerve edema in patients on peripheral hemodialysis. Ophthalmology (2007) 0.83
Effects of elevated thyroid hormone on adult rabbit extraocular muscles. Invest Ophthalmol Vis Sci (2009) 0.83
Simultaneous endoscopic antrostomy and orbital reconstruction in silent sinus syndrome. Orbit (2006) 0.83
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophthalmol (2011) 0.82
Normal exophthalmometry measurements in a United States pediatric population. Ophthal Plast Reconstr Surg (2012) 0.82
Endoscopic approach to the orbital apex and periorbital skull base. Laryngoscope (2011) 0.82
Update on thyroid eye disease and management. Clin Ophthalmol (2009) 0.82
Atypical Leber Hereditary Optic Neuropathy: 18 Year Interval Between Eyes. J Neuroophthalmol (2016) 0.82
Retinal nerve fiber layer thickness using spectral-domain optical coherence tomography in patients with no light perception secondary to optic atrophy. J Neuroophthalmol (2013) 0.82
Incidence of ocular injury in visually asymptomatic orbital fractures. Ophthal Plast Reconstr Surg (2009) 0.82
Excision of periorbital hemangiomas to correct visual abnormalities. Arch Facial Plast Surg (2011) 0.81
Arthroscopic versus open ankle arthrodesis: a retrospective cost analysis. J Foot Ankle Surg (2010) 0.81
Stent thrombosis with drug-eluting stents: a re-examination of the evidence. Catheter Cardiovasc Interv (2007) 0.81
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experience. Int J Cardiol (2012) 0.80
Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies. J Cardiovasc Med (Hagerstown) (2013) 0.80
Lash ptosis in congenital and acquired blepharoptosis. Arch Ophthalmol (2007) 0.80
Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis (2014) 0.80
Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle. Invest Ophthalmol Vis Sci (2011) 0.80
Is there treatment for traumatic optic neuropathy? Curr Opin Ophthalmol (2015) 0.79
Revised Cardiac Risk Index (RCRI) is a useful tool for evaluation of perioperative cardiac morbidity in kidney transplant recipients. Transplantation (2013) 0.79
The woman who needed a pet. Surv Ophthalmol (2006) 0.79
Isolated optic nerve lymphoma diagnosed by optic nerve biopsy. Am J Ophthalmol (2005) 0.79
Clinical manifestations and treatment of adult-onset asthma and periocular xanthogranuloma. Can Respir J (2009) 0.79
Can computationally designed protein sequences improve secondary structure prediction? Protein Eng Des Sel (2011) 0.78
Nonarteritic anterior ischemic optic neuropathy and 'visual field defects' following vitrectomy: could they be related? Graefes Arch Clin Exp Ophthalmol (2006) 0.78
Transorbital and transnasal endoscopic repair of a meningoencephalocele. Orbit (2011) 0.78
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). J Am Coll Cardiol (2009) 0.78
A multi-centre case series investigating the aetiology of hypertrophic pachymeningitis with orbital inflammation. Orbit (2011) 0.78
Characterization and multiparameter analysis of visual adverse events in irofulven single-agent phase I and II trials. Clin Cancer Res (2004) 0.78
The role of conjunctival biopsy in the diagnosis of Wegener's granulomatosis: a case report. Can J Ophthalmol (2002) 0.78
Uveitis associated with West Nile virus infection. Arch Ophthalmol (2003) 0.78
Orbital Involvement by NUT Midline Carcinoma. Ophthal Plast Reconstr Surg (2015) 0.78
Coronary perforation after percutaneous coronary intervention successfully treated with local thrombin injection. J Invasive Cardiol (2006) 0.78
Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention. J Am Coll Cardiol (2013) 0.78